A Randomized, Double-Blind, Placebo- and Active-Controlled, 4-Period Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects

Trial Profile

A Randomized, Double-Blind, Placebo- and Active-Controlled, 4-Period Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Nov 2017

At a glance

  • Drugs Lemborexant (Primary) ; Zopiclone
  • Indications Insomnia
  • Focus Pharmacodynamics
  • Sponsors Eisai Inc
  • Most Recent Events

    • 27 Mar 2017 Status changed from recruiting to completed.
    • 17 Dec 2016 Planned End Date changed from 1 Dec 2016 to 1 Feb 2017.
    • 17 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top